The global Terlipressin for Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Lumps Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Terlipressin for Injection include Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc, EVER Pharma, Alliance Pharmaceuticals, Serum Institute of India Pvt. Ltd, Biovenice Criticure and Criticine Care, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Terlipressin for injection is a synthetic polypeptide that is an analog of the hormone secreted by the posterior pituitary gland. After injection, its triglycyl group will be cleaved by enzymes in the body to slowly release active substances such as vasopressin, which can contract smooth muscles and last for 10 hours. Vasopressin mainly has two effects: one is the obvious vasoconstriction effect, thereby reducing the venous blood flow to the hepatic portal system, thereby lowering the portal blood pressure and having a hemostatic effect; Body, prevent excessive loss of water in urine, has anti-enuresis function. Terlipressin for injection lowers HVPG faster, stronger, and longer, and it is a drug for the treatment of complications of portal hypertension.
This report aims to provide a comprehensive presentation of the global market for Terlipressin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terlipressin for Injection. This report contains market size and forecasts of Terlipressin for Injection in global, including the following market information:
Global Terlipressin for Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Terlipressin for Injection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Terlipressin for Injection companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Terlipressin for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Terlipressin for Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Terlipressin for Injection Market Segment Percentages, by Type, 2022 (%)
Lumps
Powder
Global Terlipressin for Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Terlipressin for Injection Market Segment Percentages, by Application, 2022 (%)
Internal Medicine Application
surgical application
Intensive Care Unit (ICU) Applications
Global Terlipressin for Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Terlipressin for Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Terlipressin for Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Terlipressin for Injection revenues share in global market, 2022 (%)
Key companies Terlipressin for Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Terlipressin for Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ferring Pharmaceuticals
Ranbaxy UK Ltd
TAJ LIFE SCIENCES
Mallinckrodt plc
EVER Pharma
Alliance Pharmaceuticals
Serum Institute of India Pvt. Ltd
Biovenice Criticure
Criticine Care
Integrated Laboratories Pvt Ltd
Hybio Pharmaceutical Co., Ltd
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
Hangzhou Ausia Biological Technology Company, Ltd
Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
Hainan General Sanyang Pharmaceutical Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Terlipressin for Injection, market overview.
Chapter 2: Global Terlipressin for Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Terlipressin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Terlipressin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Terlipressin for Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Terlipressin for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Terlipressin for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Terlipressin for Injection Overall Market Size
2.1 Global Terlipressin for Injection Market Size: 2022 VS 2029
2.2 Global Terlipressin for Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Terlipressin for Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Terlipressin for Injection Players in Global Market
3.2 Top Global Terlipressin for Injection Companies Ranked by Revenue
3.3 Global Terlipressin for Injection Revenue by Companies
3.4 Global Terlipressin for Injection Sales by Companies
3.5 Global Terlipressin for Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Terlipressin for Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Terlipressin for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Terlipressin for Injection Players in Global Market
3.8.1 List of Global Tier 1 Terlipressin for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Terlipressin for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Terlipressin for Injection Market Size Markets, 2022 & 2029
4.1.2 Lumps
4.1.3 Powder
4.2 By Type - Global Terlipressin for Injection Revenue & Forecasts
4.2.1 By Type - Global Terlipressin for Injection Revenue, 2018-2023
4.2.2 By Type - Global Terlipressin for Injection Revenue, 2024-2029
4.2.3 By Type - Global Terlipressin for Injection Revenue Market Share, 2018-2029
4.3 By Type - Global Terlipressin for Injection Sales & Forecasts
4.3.1 By Type - Global Terlipressin for Injection Sales, 2018-2023
4.3.2 By Type - Global Terlipressin for Injection Sales, 2024-2029
4.3.3 By Type - Global Terlipressin for Injection Sales Market Share, 2018-2029
4.4 By Type - Global Terlipressin for Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Terlipressin for Injection Market Size, 2022 & 2029
5.1.2 Internal Medicine Application
5.1.3 surgical application
5.1.4 Intensive Care Unit (ICU) Applications
5.2 By Application - Global Terlipressin for Injection Revenue & Forecasts
5.2.1 By Application - Global Terlipressin for Injection Revenue, 2018-2023
5.2.2 By Application - Global Terlipressin for Injection Revenue, 2024-2029
5.2.3 By Application - Global Terlipressin for Injection Revenue Market Share, 2018-2029
5.3 By Application - Global Terlipressin for Injection Sales & Forecasts
5.3.1 By Application - Global Terlipressin for Injection Sales, 2018-2023
5.3.2 By Application - Global Terlipressin for Injection Sales, 2024-2029
5.3.3 By Application - Global Terlipressin for Injection Sales Market Share, 2018-2029
5.4 By Application - Global Terlipressin for Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Terlipressin for Injection Market Size, 2022 & 2029
6.2 By Region - Global Terlipressin for Injection Revenue & Forecasts
6.2.1 By Region - Global Terlipressin for Injection Revenue, 2018-2023
6.2.2 By Region - Global Terlipressin for Injection Revenue, 2024-2029
6.2.3 By Region - Global Terlipressin for Injection Revenue Market Share, 2018-2029
6.3 By Region - Global Terlipressin for Injection Sales & Forecasts
6.3.1 By Region - Global Terlipressin for Injection Sales, 2018-2023
6.3.2 By Region - Global Terlipressin for Injection Sales, 2024-2029
6.3.3 By Region - Global Terlipressin for Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Terlipressin for Injection Revenue, 2018-2029
6.4.2 By Country - North America Terlipressin for Injection Sales, 2018-2029
6.4.3 US Terlipressin for Injection Market Size, 2018-2029
6.4.4 Canada Terlipressin for Injection Market Size, 2018-2029
6.4.5 Mexico Terlipressin for Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Terlipressin for Injection Revenue, 2018-2029
6.5.2 By Country - Europe Terlipressin for Injection Sales, 2018-2029
6.5.3 Germany Terlipressin for Injection Market Size, 2018-2029
6.5.4 France Terlipressin for Injection Market Size, 2018-2029
6.5.5 U.K. Terlipressin for Injection Market Size, 2018-2029
6.5.6 Italy Terlipressin for Injection Market Size, 2018-2029
6.5.7 Russia Terlipressin for Injection Market Size, 2018-2029
6.5.8 Nordic Countries Terlipressin for Injection Market Size, 2018-2029
6.5.9 Benelux Terlipressin for Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Terlipressin for Injection Revenue, 2018-2029
6.6.2 By Region - Asia Terlipressin for Injection Sales, 2018-2029
6.6.3 China Terlipressin for Injection Market Size, 2018-2029
6.6.4 Japan Terlipressin for Injection Market Size, 2018-2029
6.6.5 South Korea Terlipressin for Injection Market Size, 2018-2029
6.6.6 Southeast Asia Terlipressin for Injection Market Size, 2018-2029
6.6.7 India Terlipressin for Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Terlipressin for Injection Revenue, 2018-2029
6.7.2 By Country - South America Terlipressin for Injection Sales, 2018-2029
6.7.3 Brazil Terlipressin for Injection Market Size, 2018-2029
6.7.4 Argentina Terlipressin for Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Terlipressin for Injection Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Terlipressin for Injection Sales, 2018-2029
6.8.3 Turkey Terlipressin for Injection Market Size, 2018-2029
6.8.4 Israel Terlipressin for Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Terlipressin for Injection Market Size, 2018-2029
6.8.6 UAE Terlipressin for Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ferring Pharmaceuticals
7.1.1 Ferring Pharmaceuticals Company Summary
7.1.2 Ferring Pharmaceuticals Business Overview
7.1.3 Ferring Pharmaceuticals Terlipressin for Injection Major Product Offerings
7.1.4 Ferring Pharmaceuticals Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.1.5 Ferring Pharmaceuticals Key News & Latest Developments
7.2 Ranbaxy UK Ltd
7.2.1 Ranbaxy UK Ltd Company Summary
7.2.2 Ranbaxy UK Ltd Business Overview
7.2.3 Ranbaxy UK Ltd Terlipressin for Injection Major Product Offerings
7.2.4 Ranbaxy UK Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.2.5 Ranbaxy UK Ltd Key News & Latest Developments
7.3 TAJ LIFE SCIENCES
7.3.1 TAJ LIFE SCIENCES Company Summary
7.3.2 TAJ LIFE SCIENCES Business Overview
7.3.3 TAJ LIFE SCIENCES Terlipressin for Injection Major Product Offerings
7.3.4 TAJ LIFE SCIENCES Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.3.5 TAJ LIFE SCIENCES Key News & Latest Developments
7.4 Mallinckrodt plc
7.4.1 Mallinckrodt plc Company Summary
7.4.2 Mallinckrodt plc Business Overview
7.4.3 Mallinckrodt plc Terlipressin for Injection Major Product Offerings
7.4.4 Mallinckrodt plc Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.4.5 Mallinckrodt plc Key News & Latest Developments
7.5 EVER Pharma
7.5.1 EVER Pharma Company Summary
7.5.2 EVER Pharma Business Overview
7.5.3 EVER Pharma Terlipressin for Injection Major Product Offerings
7.5.4 EVER Pharma Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.5.5 EVER Pharma Key News & Latest Developments
7.6 Alliance Pharmaceuticals
7.6.1 Alliance Pharmaceuticals Company Summary
7.6.2 Alliance Pharmaceuticals Business Overview
7.6.3 Alliance Pharmaceuticals Terlipressin for Injection Major Product Offerings
7.6.4 Alliance Pharmaceuticals Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.6.5 Alliance Pharmaceuticals Key News & Latest Developments
7.7 Serum Institute of India Pvt. Ltd
7.7.1 Serum Institute of India Pvt. Ltd Company Summary
7.7.2 Serum Institute of India Pvt. Ltd Business Overview
7.7.3 Serum Institute of India Pvt. Ltd Terlipressin for Injection Major Product Offerings
7.7.4 Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.7.5 Serum Institute of India Pvt. Ltd Key News & Latest Developments
7.8 Biovenice Criticure
7.8.1 Biovenice Criticure Company Summary
7.8.2 Biovenice Criticure Business Overview
7.8.3 Biovenice Criticure Terlipressin for Injection Major Product Offerings
7.8.4 Biovenice Criticure Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.8.5 Biovenice Criticure Key News & Latest Developments
7.9 Criticine Care
7.9.1 Criticine Care Company Summary
7.9.2 Criticine Care Business Overview
7.9.3 Criticine Care Terlipressin for Injection Major Product Offerings
7.9.4 Criticine Care Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.9.5 Criticine Care Key News & Latest Developments
7.10 Integrated Laboratories Pvt Ltd
7.10.1 Integrated Laboratories Pvt Ltd Company Summary
7.10.2 Integrated Laboratories Pvt Ltd Business Overview
7.10.3 Integrated Laboratories Pvt Ltd Terlipressin for Injection Major Product Offerings
7.10.4 Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.10.5 Integrated Laboratories Pvt Ltd Key News & Latest Developments
7.11 Hybio Pharmaceutical Co., Ltd
7.11.1 Hybio Pharmaceutical Co., Ltd Company Summary
7.11.2 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Business Overview
7.11.3 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Major Product Offerings
7.11.4 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.11.5 Hybio Pharmaceutical Co., Ltd Key News & Latest Developments
7.12 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
7.12.1 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Summary
7.12.2 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Business Overview
7.12.3 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Major Product Offerings
7.12.4 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.12.5 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Key News & Latest Developments
7.13 Hangzhou Ausia Biological Technology Company, Ltd
7.13.1 Hangzhou Ausia Biological Technology Company, Ltd Company Summary
7.13.2 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Business Overview
7.13.3 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Major Product Offerings
7.13.4 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.13.5 Hangzhou Ausia Biological Technology Company, Ltd Key News & Latest Developments
7.14 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
7.14.1 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Summary
7.14.2 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Business Overview
7.14.3 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Major Product Offerings
7.14.4 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.14.5 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Key News & Latest Developments
7.15 Hainan General Sanyang Pharmaceutical Co., Ltd
7.15.1 Hainan General Sanyang Pharmaceutical Co., Ltd Company Summary
7.15.2 Hainan General Sanyang Pharmaceutical Co., Ltd Business Overview
7.15.3 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Major Product Offerings
7.15.4 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales and Revenue in Global (2018-2023)
7.15.5 Hainan General Sanyang Pharmaceutical Co., Ltd Key News & Latest Developments
8 Global Terlipressin for Injection Production Capacity, Analysis
8.1 Global Terlipressin for Injection Production Capacity, 2018-2029
8.2 Terlipressin for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Terlipressin for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Terlipressin for Injection Supply Chain Analysis
10.1 Terlipressin for Injection Industry Value Chain
10.2 Terlipressin for Injection Upstream Market
10.3 Terlipressin for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Terlipressin for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report